Mr. Miguel Martin reports
AURORA CANNABIS TO HOST FIRST QUARTER FISCAL YEAR 2021 INVESTOR CONFERENCE CALL
Aurora Cannabis Inc. has scheduled a conference call to discuss the results for its first quarter fiscal year 2021 ended Sept. 30, 2020, on Monday, Nov. 9, 2020, at 8:30 a.m. Eastern Time. Miguel Martin, chief executive officer, and Glen Ibbott, chief financial officer, will host the call and a question-and-answer period. The company will provide its financial results for the first quarter before the open of markets on Monday, Nov. 9, 2020.
First quarter fiscal year 2021 conference call details
Date: Monday, Nov. 9, 2020
Time: 8:30 a.m. Eastern Time, 6:30 a.m. Mountain Time
Webcast: available on-line
Updates to director compensation plans
To support the company's goal of fair and competitive compensation, Aurora has formalized certain existing compensation principles in its share compensation plans regarding, in particular, non-employee director compensation.
Beginning in July, 2019, the company implemented an annual maximum of $150,000 of equity compensation for non-employee directors. The company has now codified this as a key term in the company's share compensation plans, including the RSU, DSU (deferred share units) and stock option plan. The new amendments provide that non-employee directors' compensation will be limited to no more than $150,000 in equity awards per year, of which no more than $97,500 can be in the form of stock options. This limit applies to all equity awards received by non-employee directors, except for the portion of their annual cash retainer and board fees elected to be received in deferred share units (DSUs).
Additionally, the company has added a restriction in the deferred share unit plan that prohibits the company from granting DSUs to the non-employee directors on a discretionary basis.
Finally, and in line with the company's objective of achieving and maintaining fair and competitive compensation, the company has implemented a performance share unit plan, which is subject to shareholder approval at the company's annual and special general meeting on Nov. 12, 2020. Pursuant to the terms of the performance share unit plan, non-employee directors are not eligible to participate.
About Aurora Cannabis Inc.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva. Providing customers with innovative, high-quality cannabis and hemp products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.